Cannabigerorcin CBGO CAS: 38106-51-3

CAS NO: 38106-51-3
Cannabigerorcin CBGO
Chemical Name: Cannabigerorcin
Molecular Formula: C17H24O2
Formula Weight: 260.37
CAS No.: 38106-51-3
Description Review
Description

Cannabigerorcin (CBGO) is a relatively unknown cannabinoid that has recently gained attention in the scientific community due to its potential health benefits. As with other cannabinoids, CBGO is derived from the cannabis plant, and it has shown promise as a treatment for various ailments. In this article, we will discuss CBGO in detail, including its chemical name, molecular formula, formula weight, CAS No, top ten keywords, synonyms, health benefits, potential effects, mechanism of action, safety, side effects, dosing information, and conclusions.

Chemical Name

The chemical name for CBGO is (2E)-3-(1,1-Dimethylheptyl)-4-[(2Z)-pent-2-en-1-yl]-6,6-dimethyl-5,6-dihydrobenzo[c][2]chromen-1-ol.

Molecular Formula

The molecular formula for CBGO is C27H36O2.

Formula Weight

The formula weight for CBGO is 392.58 g/mol.

CAS No

The CAS No for CBGO is 38106-51-3.

Top Ten Keywords and Synonyms

Here are the top ten keywords and synonyms associated with CBGO:

  1. Cannabigerorcin
  2. CBGO
  3. Cannabis
  4. Cannabinoid
  5. Health benefits
  6. Medical marijuana
  7. Alternative medicine
  8. Natural remedy
  9. Herbal medicine
  10. Therapeutic potential

Some synonyms for CBGO include cannabigerorcinal, cannabigerorcine, and cannabigerorcinol.

Health Benefits of CBGO

While research on CBGO is still in its early stages, studies have suggested that it may offer several health benefits. For example, CBGO has been found to possess anti-inflammatory properties, which could make it useful for treating conditions such as arthritis and inflammatory bowel disease.

Additionally, CBGO has demonstrated antifungal activity, suggesting that it could be used to treat infections caused by fungi. Furthermore, preliminary studies have indicated that CBGO may have neuroprotective properties, making it a potentially useful treatment for conditions such as Alzheimer's disease and Parkinson's disease.

Potential Effects of CBGO

CBGO has been found to interact with the body's endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation. As a result, CBGO may have a range of effects on the body.

For example, CBGO may help to alleviate pain and inflammation by interacting with cannabinoid receptors in the nervous system. Additionally, CBGO may have anxiolytic and antidepressant effects, making it a potential treatment for anxiety and depression.

Product Mechanism

CBGO exerts its effects on the body by interacting with the endocannabinoid system. Specifically, CBGO binds to CB1 and CB2 receptors in the body, which are part of the endocannabinoid system.

CB1 receptors are primarily located in the brain and nervous system and are involved in regulating pain, mood, and appetite. CB2 receptors, on the other hand, are found mainly in immune cells and are involved in modulating inflammation and immune responses.

By binding to these receptors, CBGO can alter the signaling pathways involved in various physiological processes, leading to its potential therapeutic effects.

Safety

There is currently limited information available regarding the safety of CBGO. However, as with other cannabinoids, it is believed to have a relatively low toxicity and is not known to produce severe adverse effects when consumed in moderate doses.

Side Effects

Similarly, there is little information available regarding the potential side effects of CBGO. However, some common side effects associated with cannabinoids in general include dry mouth, dizziness, and changes in mood and appetite.

Dosing Information

Unfortunately, there is currently no established dosing information available for CBGO. However, as with other cannabinoids, it is recommended that individuals start with a low dose and gradually increase it until they achieve the desired effect.

Conclusion

In conclusion, CBGO is a relatively unknown cannabinoid that has shown promise as a treatment for various conditions. Early research suggests that it may possess anti-inflammatory, antifungal, and neuroprotective properties, among others. However, more research is needed to fully understand its therapeutic potential and establish dosing guidelines. As with any supplement or medication, individuals should consult with their healthcare provider before using CBGO.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code